Literature DB >> 9659277

Neuroendocrine cell hyperplasia in colonic tissue used for long term augmentation cystoplasty.

K Oien1, M Akyol, G Lindop.   

Abstract

A case is described of neuroendocrine cell hyperplasia in intravesical colonic mucosa, implanted previously during augmentation cystoplasty. The patient was a 28 year old man born with posterior urethral valves, a non-functioning right kidney, and a poorly functioning dilated left kidney. The hyperplasia consisted of pure neuroendocrine acini and tubules within the lamina propria, separate from the normal intestinal glands. Adjacent intraepithelial colonic neuroendocrine cells were increased diffusely. Rectal biopsy and previous biopsies of intravesical colonic tissue contained normal neuroendocrine cell populations. Implantation of gut segments into the urinary tract predisposes to late neoplasia, but there is only one report of carcinoid tumour in uroenteric tissue. Intestinal neuroendocrine cell hyperplasia usually occurs diffusely rather than as aggregates, except when associated with adjacent carcinoid tumour. Both diffuse and nodular hyperplasia were present in this case, with an unusual and striking morphology. This is the first report of neuroendocrine cell hyperplasia in gastrointestinal tissue implanted into the urinary tract; this raises the possibility of a risk of late carcinoid tumour in uroenteric segments.

Entities:  

Mesh:

Year:  1998        PMID: 9659277      PMCID: PMC500656          DOI: 10.1136/jcp.51.3.258

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

Review 1.  Malignancies in bladder augmentations and intestinal conduits.

Authors:  R B Filmer; J R Spencer
Journal:  J Urol       Date:  1990-04       Impact factor: 7.450

2.  Hyperplastic lesions of the gastrointestinal endocrine cells.

Authors:  Y Dayal; R A DeLellis; H J Wolfe
Journal:  Am J Surg Pathol       Date:  1987       Impact factor: 6.394

Review 3.  Gastrointestinal endocrine cells and carcinoids. Histogenetic and pathogenetic considerations.

Authors:  T N Moyana
Journal:  Pathol Annu       Date:  1995

4.  Enterochromaffin cell hyperplasia and megacolon: report of a case.

Authors:  G B Lindop
Journal:  Gut       Date:  1983-06       Impact factor: 23.059

Review 5.  Current status of tumor of the bowel following ureterosigmoidostomy: a review.

Authors:  D A Husmann; H M Spence
Journal:  J Urol       Date:  1990-09       Impact factor: 7.450

6.  Adenocarcinoid tumor, goblet cell type, arising in a ureteroileal conduit: a case report.

Authors:  J Kochevar
Journal:  J Urol       Date:  1984-05       Impact factor: 7.450

7.  Gastric function and histology in chronic renal failure.

Authors:  C J Mitchell; D P Jewell; M R Lewin; J E McLaughlin; J F Moorhead
Journal:  J Clin Pathol       Date:  1979-03       Impact factor: 3.411

8.  Long-term histopathological changes observed in rats subjected to augmentation cystoplasty.

Authors:  J S Little; L W Klee; D M Hoover; R C Rink
Journal:  J Urol       Date:  1994-08       Impact factor: 7.450

9.  Changes in the mucosa of colon conduits with particular reference to the risk of malignant change.

Authors:  J Moorcraft; C E DuBoulay; P Isaacson; J D Atwell
Journal:  Br J Urol       Date:  1983-04

10.  Late malignancy in bowel segments exposed to urine without fecal stream.

Authors:  A A Shokeir; M Shamaa; M M el-Mekresh; M el-Baz; M A Ghoneim
Journal:  Urology       Date:  1995-11       Impact factor: 2.649

  10 in total
  2 in total

1.  Neuroendocrine dysplasia combined in a tubular adenoma of rectum: a case report.

Authors:  So-Young Lee; Dae-Yong Hwang; Tae Sook Hwang; Wan-Seop Kim; So Dug Lim; Wook Youn Kim; Se-Hun Kim; Hye Seung Han
Journal:  Korean J Pathol       Date:  2013-10-25

2.  Colorectal microcarcinoids in association with long-term exposure to urinary content: a case report and review of the literature.

Authors:  Grace W Weyant; Dipti M Karamchandani; Negar Rassaei
Journal:  Case Rep Pathol       Date:  2015-04-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.